John Paolini F.'s most recent trade in Kiniksa Pharmaceuticals Ltd - Ordinary Shares - Class A was a trade of 82,542 Class A Ordinary Share done at an average price of $37.1 . Disclosure was reported to the exchange on Oct. 31, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 37.14 per share. | 31 Oct 2025 | 82,542 | 61,324 (0%) | 0% | 37.1 | 3,065,610 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.83 per share. | 31 Oct 2025 | 46,000 | 143,866 (0%) | 0% | 8.8 | 406,180 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 46,000 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Oct 2025 | 36,542 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 31 Oct 2025 | 36,542 | 97,866 (0%) | 0% | 3.8 | 138,860 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 39,364 | 39,364 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2025 | 9,828 | 9,828 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.49 per share. | 01 Sep 2025 | 2,841 | 60,434 (0%) | 0% | 33.5 | 95,145 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 2,498 | 2,497 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 2,498 | 63,275 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 1,750 | 59,153 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 1,750 | 5,250 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 1,725 | 0 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 1,725 | 62,159 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 1,624 | 60,777 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2025 | 1,624 | 3,248 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.28 per share. | 01 Sep 2025 | 835 | 61,324 (0%) | 0% | 34.3 | 28,624 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 29,325 | 36,542 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 32.55 per share. | 06 Aug 2025 | 29,325 | 57,403 (0%) | 0% | 32.6 | 954,529 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 06 Aug 2025 | 29,325 | 86,728 (0%) | 0% | 3.8 | 111,435 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2025 | 200 | 65,867 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 07 May 2025 | 200 | 57,403 (0%) | 0% | 27 | 5,400 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 07 May 2025 | 200 | 57,603 (0%) | 0% | 3.8 | 760 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 8,266 | 8,266 | - | - | Performance Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 8,007 | 8,007 | - | - | Performance Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 5,201 | 5,201 | - | - | Performance Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2025 | 4,954 | 4,954 | - | - | Performance Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 2,498 | 58,137 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Apr 2025 | 2,498 | 2,497 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.28 per share. | 07 Apr 2025 | 734 | 57,403 (0%) | 0% | 20.3 | 14,886 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 39,364 | 39,364 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 19,657 | 19,657 | - | - | Performance Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 9,828 | 9,828 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,750 | 5,250 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,750 | 56,630 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,624 | 54,880 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 1,624 | 3,248 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.77 per share. | 01 Apr 2025 | 514 | 55,639 (0%) | 0% | 21.8 | 11,190 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 21.77 per share. | 01 Apr 2025 | 477 | 56,153 (0%) | 0% | 21.8 | 10,384 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2025 | 1,725 | 0 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2025 | 1,725 | 53,763 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 22.61 per share. | 16 Mar 2025 | 507 | 53,256 (0%) | 0% | 22.6 | 11,463 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 60,217 | 0 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 01 Sep 2024 | 60,217 | 112,255 (0%) | 0% | 1.9 | 112,004 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.09 per share. | 01 Sep 2024 | 59,214 | 53,516 (0%) | 0% | 26.1 | 1,544,893 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 36,350 | 36,350 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 7,000 | 7,000 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 4,121 | 53,142 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 2,497 | 4,995 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.74 per share. | 01 Sep 2024 | 1,994 | 51,148 (0%) | 0% | 26.7 | 53,320 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,725 | 1,725 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,725 | 52,873 (0%) | 0% | - | Class A Ordinary Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,624 | 4,872 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.13 per share. | 01 Sep 2024 | 1,478 | 52,038 (0%) | 0% | 27.1 | 40,098 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.74 per share. | 01 Sep 2024 | 835 | 52,038 (0%) | 0% | 26.7 | 22,328 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 475 | 44,549 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.80 per share. | 01 Sep 2024 | 475 | 112,730 (0%) | 0% | 3.8 | 1,805 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 23 Jul 2024 | 22,000 | 69,803 (0%) | 0% | 1.9 | 40,920 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jul 2024 | 22,000 | 60,217 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.10 per share. | 23 Jul 2024 | 8,446 | 47,903 (0%) | 0% | 27.1 | 228,887 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 26.36 per share. | 23 Jul 2024 | 7,924 | 56,349 (0%) | 0% | 26.4 | 208,877 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 23 Jul 2024 | 5,530 | 64,273 (0%) | 0% | 25.0 | 138,416 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.87 per share. | 23 Jul 2024 | 100 | 47,803 (0%) | 0% | 27.9 | 2,787 | Class A Ordinary Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 36,350 | 36,350 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 7,000 | 11,872 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2024 | 5,600 | 5,600 | - | - | Performance Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 2,497 | 48,536 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 2,497 | 9,375 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 17.90 per share. | 04 Apr 2024 | 733 | 47,803 (0%) | 0% | 17.9 | 13,121 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 1,624 | 46,516 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 1,624 | 4,872 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.70 per share. | 01 Apr 2024 | 477 | 46,039 (0%) | 0% | 19.7 | 9,397 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2024 | 18,844 | 82,217 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 21.77 per share. | 01 Mar 2024 | 18,844 | 44,892 (0%) | 0% | 21.8 | 410,234 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 01 Mar 2024 | 18,844 | 62,736 (0%) | 0% | 1.9 | 35,050 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 27 Feb 2024 | 10,156 | 55,048 (0%) | 0% | 1.9 | 18,890 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John Paolini F. | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 10,156 | 101,061 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John Paolini F. | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 21.03 per share. | 27 Feb 2024 | 10,156 | 44,892 (0%) | 0% | 21.0 | 213,581 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | Paolini John F. | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 07 Dec 2023 | 28,600 | 73,492 (0%) | 0% | 1.9 | 53,196 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | F. John Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2023 | 28,600 | 111,217 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.64 per share. | 07 Dec 2023 | 13,017 | 53,095 (0%) | 0% | 17.6 | 229,620 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.54 per share. | 07 Dec 2023 | 7,380 | 66,112 (0%) | 0% | 17.5 | 129,445 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | Paolini F. John | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.75 per share. | 07 Dec 2023 | 6,702 | 46,393 (0%) | 0% | 17.8 | 118,961 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | F. John Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 17.81 per share. | 07 Dec 2023 | 1,501 | 44,892 (0%) | 0% | 17.8 | 26,733 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 25 Jul 2023 | 29,000 | 70,910 (0%) | 0% | 1.9 | 53,940 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jul 2023 | 29,000 | 140,217 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.25 per share. | 25 Jul 2023 | 16,168 | 49,542 (0%) | 0% | 19.3 | 311,234 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 19.69 per share. | 25 Jul 2023 | 7,632 | 41,910 (0%) | 0% | 19.7 | 150,274 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 25 Jul 2023 | 5,200 | 65,710 (0%) | 0% | 18.0 | 93,652 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2023 | 2,498 | 42,644 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2023 | 2,498 | 7,492 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.71 per share. | 10 Apr 2023 | 734 | 41,910 (0%) | 0% | 10.7 | 7,861 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 38,974 | 38,974 | - | - | Share Option | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 6,496 | 6,496 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 3,671 | 0 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 3,671 | 41,224 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 1,725 | 3,450 | - | - | Restricted Share Unit | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Mar 2023 | 1,725 | 38,060 (0%) | 0% | - | Class A Common Share | |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.12 per share. | 16 Mar 2023 | 1,078 | 40,146 (0%) | 0% | 11.1 | 11,987 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.46 per share. | 16 Mar 2023 | 507 | 37,553 (0%) | 0% | 11.5 | 5,810 | Class A Common Share |
| Kiniksa Pharma Ltd (Class A) | John F. Paolini | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.86 per share. | 07 Nov 2022 | 28,357 | 64,692 (0%) | 0% | 1.9 | 52,744 | Class A Common Share |